AIDS 2024 Co-Chairs' Choice

Chairs
Sharon Lewin

Sharon Lewin

Peter Doherty Institute for Infection and Immunity

Andriy Klepikov

Andriy Klepikov

Alliance for Public Health

Christoph Spinner

University Hospital rechts der Isar, Technical University of Munich

Speakers
Sharon Lewin

Sharon Lewin

Peter Doherty Institute for Infection and Immunity

Christoph Spinner

University Hospital rechts der Isar, Technical University of Munich

Andriy Klepikov

Andriy Klepikov

Alliance for Public Health

Introduction

Christian Gaebler

Charité – Universitätsmedizin Berlin, corporate member of Freie Universität and Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany

The next Berlin patient: sustained HIV remission surpassing five years without antiretroviral therapy after heterozygous CCR5 WT/?32 allogeneic hematopoietic stem cell transplantation

Gary Blick

Health Care Advocates International

No confirmed virological failures (CVF) for 144 weeks when switching 2-/3-/4-drug ART to DTG/3TC in heavily treatment-experienced PLWHA with prior M184V/I and virological failures (VF) in the prospective SOLAR-3D study

Béatrice Bercot

IAME UMR1137, Assistance-Publique Hôpitaux de Paris, University of Paris Cité

Antimicrobial resistance in Neisseria gonorrhoeae infections among MSM on Doxycycline post-exposure prophylaxis

Nigel Garrett

Centre for the AIDS Programme of Research in South Africa

Tenofovir-diphosphate concentrations and viral suppression following monthly point-of-care urine tenofovir testing among adults initiating antiretroviral therapy: primary outcome of the randomised controlled STREAM HIV trial

Ruslan Poverga

Public Association "Positive Initiative"

Automated 24/7 dispensing of HIV prevention goods and self-tests via vending machines

Linda-Gail Bekker

Desmond Tutu Health Foundation

Twice-Yearly Lenacapavir or Daily Emtricitabine/Tenofovir Alafenamide for HIV Prevention in Cisgender Women: Interim Analysis Results from the PURPOSE 1 Study
Sharon Lewin

Sharon Lewin

Peter Doherty Institute for Infection and Immunity

Christoph Spinner

University Hospital rechts der Isar, Technical University of Munich

Andriy Klepikov

Alliance for Public Health

Christian Gaebler

Charité - Universitätsmedizin Berlin

Gary Blick

Health Care Advocates International

Béatrice Bercot

IAME UMR1137, Assistance-Publique Hôpitaux de Paris, University of Paris Cité

Nigel Garrett

Centre for the AIDS Programme of Research in South Africa

Ruslan Poverga

Public Association "Positive Initiative"

Linda-Gail Bekker

Linda-Gail Bekker

Desmond Tutu HIV Centre

Q&A and conclusion
Sharon Lewin

Sharon Lewin

Peter Doherty Institute for Infection and Immunity

IAS President’s Award